RHRoman L. Haberl

Roman L. Haberl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roman L. Haberl has a total of 177 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    One-year functional outcome of the Flying Intervention Team versus patient interhospital transfer in acute ischaemic stroke

    by Nikolai D Hubert, Markus Holler, Saskia R Wernsdorf, Sophie Herdegen, Christian Maegerlein, Hanni Wiestler, Lucie Esterl-Pfäffl, Dennis Dietrich, Thomas Witton-Davies, Isabel Heinrich, et al.

    Introduction: Endovascular thrombectomy is highly effective for large vessel occlusion strokes, yet timely access remains challenging in remote areas. The Flying Intervention Team study demonstrated that dispatching a neurointerventionist team to peripheral hospitals reduces time to treatment. This study evaluates 12-month functional outcomes of enrolled patients. Patients and methods: This is a secondary analysis of a multicentre pseudo-randomised controlled intervention study comparing 2 systems of care in alternating weeks. The study was conducted in 13 nonurban primary stroke centres in Bavaria, Germany. Of 157 patients enrolled between February 2018 and October 2019, 146 had available 12-month follow-up information. Patients were treated either by the flying team or after interhospital transfer to a referral centre. Primary outcome was the modified Rankin Scale (mRS) score at 12 months in the intention-to-treat analysis. Secondary outcomes included quality of life, activities of daily living and mortality. Results: Overall, 146 patients were included (median [IQR] age, 75 [66–80] years; 79 [54%] women), 70 in the flying team group and 76 in the transfer group. Median decision-to-puncture time was 89 min shorter in the flying team group. No significant differences were found in successful reperfusion and complication rates. mRS scores at 12 months favoured the flying team (3 [IQR 1–6] vs 4 [2–6]; adjusted common odds ratio, 2.03; 95% CI, 1.09–3.84). Surviving patients had significantly better quality of life (EQ-5D mean [SD] utility score, 0.79 [0.24] vs 0.68 [0.31]). No significant differences were observed in Barthel index or mortality. Discussion and conclusion: In rural stroke patients, deployment of a flying team was associated with better functional outcomes at 12 months. These findings reinforce the potential for broader implementation of the model to increase equitable access to stroke care.


  • Erratum

    by Craig S. Anderson, European Stroke Organization (Eso), Michael G.M. Hennerici, Narayanaswamy Venketasubramanian, Jay P. Mohr, Larry Goldstein, Jong-Sung Kim, Marc Hommel, Man Mohan Mehndiratta, Richard A. Bernstein, et al.

    Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

  • Erratum

    by Craig S. Anderson, European Stroke Organization (Eso), Michael G.M. Hennerici, Narayanaswamy Venketasubramanian, Jay P. Mohr, Larry Goldstein, Jong-Sung Kim, Marc Hommel, Man Mohan Mehndiratta, Richard A. Bernstein, et al.

    In the article “Matching Selection of Donor-Recipient Vessels in Revascularization Surgery Effectively Reduce the Incidence of Postoperative Hyperperfusion Syndrome in Adult Moyamoya Disease: A Retrospective Comparison Study” [Cerebrovasc Dis. 2020;49:361–8, DOI: 10.1159/000509138] by Hu et al., in the sub-section Postoperative Management, on page 364, the sentence “The patency of the anastomosis and the perfusion status were detected by CTA and 123I N-isopropyl-p-iodoamphetamine single-photon emission computed tomography (123I-IMP-SPECT) at postoperative days 3 and 8.” is incorrect. The sentence should read instead “The patency of the anastomosis and the perfusion status were detected by CTA and 99mTc-ethyl-cysteinate dimer single photo emission computed tomography and (99mTc-ECD–SPECT at postoperative days 3 and 8.”

  • Erratum

    by Craig S. Anderson, European Stroke Organization (Eso), Michael G.M. Hennerici, Narayanaswamy Venketasubramanian, Jay P. Mohr, Larry Goldstein, Jong-Sung Kim, Marc Hommel, Man Mohan Mehndiratta, Richard A. Bernstein, et al.

    This pertains to the article by Johansson and Acosta [2020;49:563–569. DOI: 10.1159/000510907], entitled “Diet and Lifestyle as Risk Factors for Carotid Artery Disease: A Prospective Cohort Study”. Following its publication, while analyzing new data from a database that utilized the same baseline variables as this study, the authors discovered that the baseline dataset in the database had been erroneously merged in the first place which then resulted in erroneous reporting of the results.

  • The “Flying Intervention Team”: A Novel Stroke Care Concept for Rural Areas

    by Gordian Jan Hubert, Frank Kraus, Christian Maegerlein, Sabine Platen, Benjamin Friedrich, Hans-Ulrich Kain, Thomas Witton-Davies, Nikolai Dominik Hubert, Claus Zimmer, Philip M. Bath, et al.

    Background: Endovascular treatment of large vessel occlusion in acute ischemic stroke patients is difficult to establish in remote areas, and time dependency of treatment effect increases the urge to develop health care concepts for this population. Summary: Current strategies include direct transportation of patients to a comprehensive stroke center (CSC) (“mothership model”) or transportation to the nearest primary stroke center (PSC) and secondary transfer to the CSC (“drip-and-ship model”). Both have disadvantages. We propose the model “flying intervention team.” Patients will be transported to the nearest PSC; if telemedically identified as eligible for thrombectomy, an intervention team will be acutely transported via helicopter to the PSC and endovascular treatment will be performed on site. Patients stay at the PSC for further stroke unit care. This model was implemented at a telestroke network in Germany. Fifteen remote hospitals participated in the project, covering 14,000 km2 and a population of 2 million. All have well established telemedically supported stroke units, an angiography suite, and a helicopter pad. Processes were defined individually for each hospital and training sessions were implemented for all stroke teams. An exclusive project helicopter was installed to be available from 8 a.m. to 10 p.m. during 26 weeks per year. Key Messages: The model of the flying intervention team is likely to reduce time delays since processes will be performed in parallel, rather than consecutively, and since it is quicker to move a medical team rather than a patient. This project is currently under evaluation (clinicaltrials NCT04270513).


  • Stroke Care during the COVID-19 Pandemic: International Expert Panel Review

    by Narayanaswamy Venketasubramanian, Craig Anderson, Hakan Ay, Selma Aybek, Waleed Brinjikji, Gabriel R. de Freitas, Oscar H. Del Brutto, Klaus Fassbender, Miki Fujimura, Larry B. Goldstein, et al.

    Background: Coronavirus disease 2019 (COVID-19) has placed a tremendous strain on healthcare services. This study, prepared by a large international panel of stroke experts, assesses the rapidly growing research and personal experience with COVID-19 stroke and offers recommendations for stroke management in this challenging new setting: modifications needed for prehospital emergency rescue and hyperacute care; inpatient intensive or stroke units; posthospitalization rehabilitation; follow-up including at-risk family and community; and multispecialty departmental developments in the allied professions. Summary: The severe acute respiratory syndrome coronavirus 2 uses spike proteins binding to tissue angiotensin-converting enzyme (ACE)-2 receptors, most often through the respiratory system by virus inhalation and thence to other susceptible organ systems, leading to COVID-19. Clinicians facing the many etiologies for stroke have been sobered by the unusual incidence of combined etiologies and presentations, prominent among them are vasculitis, cardiomyopathy, hypercoagulable state, and endothelial dysfunction. International standards of acute stroke management remain in force, but COVID-19 adds the burdens of personal protections for the patient, rescue, and hospital staff and for some even into the postdischarge phase. For pending COVID-19 determination and also for those shown to be COVID-19 affected, strict infection control is needed at all times to reduce spread of infection and to protect healthcare staff, using the wealth of well-described methods. For COVID-19 patients with stroke, thrombolysis and thrombectomy should be continued, and the usual early management of hypertension applies, save that recent work suggests continuing ACE inhibitors and ARBs. Prothrombotic states, some acute and severe, encourage prophylactic LMWH unless bleeding risk is high. COVID-19-related cardiomyopathy adds risk of cardioembolic stroke, where heparin or warfarin may be preferable, with experience accumulating with DOACs. As ever, arteritis can prove a difficult diagnosis, especially if not obvious on the acute angiogram done for clot extraction. This field is under rapid development and may generate management recommendations which are as yet unsettled, even undiscovered. Beyond the acute management phase, COVID-19-related stroke also forces rehabilitation services to use protective precautions. As with all stroke patients, health workers should be aware of symptoms of depression, anxiety, insomnia, and/or distress developing in their patients and caregivers. Postdischarge outpatient care currently includes continued secondary prevention measures. Although hoping a COVID-19 stroke patient can be considered cured of the virus, those concerned for contact safety can take comfort in the increasing use of telemedicine, which is itself a growing source of patient-physician contacts. Many online resources are available to patients and physicians. Like prior challenges, stroke care teams will also overcome this one. Key Messages: Evidence-based stroke management should continue to be provided throughout the patient care journey, while strict infection control measures are enforced.


  • Open Access

    Decline and Recurrence of Stroke Consultations during the COVID-19 Pandemic Lockdown Parallels Population Activity Levels

    by Felix Schlachetzki, Sibylle Wilfling, Nikolai Dominik Hubert, Andrea Wagner, Roman L. Haberl, Ralf Andreas Linker, Gordian Jan Hubert

    Background: The COVID-19 pandemic lockdown (CPL) lead to a significant decrease in emergency admissions worldwide. We performed a timely analysis of ischemic stroke (IS) and related consultations using the telestroke TEMPiS “working diagnosis” database prior (PL), within (WL), and after easing (EL) of CPL. Methods: Twelve hospitals were selected and data analyzed regarding IS (including intravenous thrombolysis [intravenous recombinant tissue plasminogen; IV rtPA] and endovascular thrombectomy [EVT]) and related events from February 1 to June 15 during 2017–2020. In addition, we aimed to correlate events to various mobile phone mobility data. Results: Following the significant reduction of IS, IV rtPA, and EVT cases during WL compared to PL in 2020 longitudinally (p values Conclusions: While the decrease in emergency admissions including stroke during CPL can only be in part attributed by patients not seeking medical attention, stroke awareness in the pandemic, and direct COVID-19 triggered stroke remains of high importance. The number of consultations in TEMPiS during the lockdown parallels best with mobility of public transportation. As a consequence, exposure to common viruses, well-known triggers for acute cerebrovascular events and other diseases, are reduced and may add to the decline in stroke consultations. Further studies comparing national responses toward the course of the COVID-19 pandemic and stroke incidences are needed.


  • Open Access

    Low stroke incidence in the TEMPiS telestroke network during COVID-19 pandemic: Effect of lockdown on thrombolysis and thrombectomy

    by Felix Schlachetzki, Carmen Theek, Nikolai D Hubert, Mustafa Kilic, Roman L Haberl, Ralf A Linker, Gordian J Hubert

    Background: During the COVID-19 pandemic emergency departments have noted a significant decrease in stroke patients. We performed a timely analysis of the Bavarian telestroke TEMPiS “working diagnosis” database. Methods: Twelve hospitals from the TEMPiS network were selected. Data collected for January through April in years 2017 through 2020 were extracted and analyzed for presumed and definite ischemic stroke (IS), amongst other disorders. In addition, recommendations for intravenous thrombolysis (rtPA) and endovascular thrombectomy (EVT) were noted and mobility data of the region analyzed. If statistically valid, group-comparison was tested with Fisher’s exact test considering unpaired observations and ap-value < 0.05 was considered significant. Results: Upon lockdown in mid-March 2020, we observed a significant reduction in recommendations for rtPA compared to the preceding three years (14.7% [2017–2019] vs. 9.2% [2020], p = 0.0232). Recommendations for EVT were significantly higher in January to mid-March 2020 compared to 2017–2019 (5.4% [2017–2019] vs. 9.3% [2020], p = 0.0013) reflecting its increasing importance. Following the COVID-19 lockdown mid-March 2020 the number of EVT decreased back to levels in 2017–2019 (7.4% [2017–2019] vs. 7.6% [2020], p = 0.1719). Absolute numbers of IS decreased in parallel to mobility data. Conclusions: The reduced stroke incidence during the COVID-19 pandemic may in part be explained by patient avoidance to seek emergency stroke care and may have an association to population mobility. Increasing mobility may induce a rebound effect and may conflict with a potential second COVID-19 wave. Telemedical networks may be ideal databases to study such effects in near-real time.


  • Prävalenz, Komorbidität und Behandlungsintensität der peripheren arteriellen Verschlusskrankheit in der Hausarztpraxis

    by J.-R. Allenberg, H.-J. Trampisch, H. Darius, S. Lange, R. Haberl, B. V. Stritzky, G. Tepohl, D. Pittrow, C. Diehm